CN2528018Y - ToRCH protein chip - Google Patents

ToRCH protein chip Download PDF

Info

Publication number
CN2528018Y
CN2528018Y CN 01263165 CN01263165U CN2528018Y CN 2528018 Y CN2528018 Y CN 2528018Y CN 01263165 CN01263165 CN 01263165 CN 01263165 U CN01263165 U CN 01263165U CN 2528018 Y CN2528018 Y CN 2528018Y
Authority
CN
China
Prior art keywords
torch
protein
film
chip
microslide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 01263165
Other languages
Chinese (zh)
Inventor
唐祖明
何农跃
陆祖宏
张春秀
王宏
梅茜
朱毅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Private Science And Technology Pioneering Center Co Ltd
Nanjing Jihui Science & Technology Co Ltd
Original Assignee
Nanjing Private Science And Technology Pioneering Center Co Ltd
Nanjing Jihui Science & Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Private Science And Technology Pioneering Center Co Ltd, Nanjing Jihui Science & Technology Co Ltd filed Critical Nanjing Private Science And Technology Pioneering Center Co Ltd
Priority to CN 01263165 priority Critical patent/CN2528018Y/en
Application granted granted Critical
Publication of CN2528018Y publication Critical patent/CN2528018Y/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

The utility model discloses a ToRCH protein chip belonging to the technical field of biochip. The protein chip comprises a glass slide; a macromolecule xylanase membrane is adhered to the glass slide; the surface of macromolecule xylanase membrane is adhered with a ToRCH antigen-antibody protein microarray. All ToRCH diagnosis can be completed by a chip at one time in a short time of about 2 hours, which is very convenient and fast; the cost is much lower than that of the examination of imported kit. Therefore, as the utility model is released, the popularity of ToRCH disease examination and diagnosis will be promoted, which will have vital and far-reaching significance for the good prenatal and postnatal care and the improvement of the quality of newborn population in China, even in the entire world.

Description

The ToRCH protein-chip
Technical field
The utility model relates to a kind of protein-chip, and especially a kind of protein-chip of diagnosing usefulness belongs to the biochip technology field.
Background technology
Nineteen nineties, a brand-new era is brought biotechnology in biochip research at the very start.Compare with the genetic chip that causes extensive concern, protein-chip can reflect the protein level in the biosome, therefore can express more complete biological information.
" ToRCH " is the technical term of modern perinatal medicine.Wherein, T represents toxoplasma gondii (Toxoplasmagondii), O represents (Other) such as Epstein-Barr virus, HIV virus and human parvovirus B19s, R represents rubella virus (Rubella Virus), C represents cytomegalovirus (Cytomegalovirus), and H represents herpes simplex I type and II type virus (Herpes Simplex Virus I and II).The scope of these pathogenic infections is wide, harm is big, and the pregnant woman is easy to take place primary infection, causes miscarriage, premature labor, stillborn foetus or growth retardation of fetus and developmental deformity, thus the population quality of having a strong impact on.
Developed countries such as America and Europe just classify it as pregnancy period examination project as far back as the seventies.Pregnant earlier T oRCH testing, especially Beijing have also progressively been carried out in China developed regions, and municipal government has issued the relevant document of ToRCH being classified as pregnant woman's routine inspection project.
At present, the complete dependence on import of kit of China ToRCH deagnostic test, it costs an arm and a leg, because the every box reagent of kit need use up in the short as far as possible time, therefore requires the number of inspection simultaneously and the dosage coupling of every box reagent.The person under inspection need spend 300-500 unit, usually will wait for that there is the result in several old name for the Arabian countries in the Middle Easts.Expensive inspection charge and loaded down with trivial details scrutiny program have limited popularizing that ToRCH checks to a great extent.
The purpose of this utility model is: at the problem of above-mentioned existing ToRCH deagnostic test reagent existence, utilize the high-tech biotechnology to propose a kind of ToRCH protein-chip, thereby the diagnosis that makes the ToRCH disease has more science, checks the diagnostic means method easily, can generally accept for hospital, patient.
In order to reach the foregoing invention purpose, the technical solution of the utility model is: the ToRCH protein-chip comprises microslide, and described microslide is attached with macromolecule glycan film, and described macromolecule glycan film surface attachment has ToRCH antigen-antibody protein microarray.
During inspection, be coated on clearly on the chip of the present utility model as long as will wait to have a blood test, if the person under inspection is by the ToRCH virus infections, its serum will be very fast with chip on corresponding antigen-antibody generation idiosyncrasy, when by fluorescence microscope, just show corresponding positive feature, like this in the short time about two hours, just can finish all ToRCH diagnosis by a slice chip is disposable, very convenient quick, its cost is significantly less than the expense that the import reagent box is checked.Therefore, after technology of the present utility model is released, will greatly promote popularizing of ToRCH disease examination, to the prenatal and postnatal care and the important and far-reaching meaning of raising newborn population quality generation in the China and even the world.
Description of drawings
Below in conjunction with accompanying drawing the technical solution of the utility model is described further.
Fig. 1 is the structural representation of technical solutions of the utility model embodiment one.
Embodiment
Embodiment one
The ToRCH protein-chip of present embodiment adopts glass as microslide 1, the upper surface of microslide 1 is attached with one deck agarose film 2, the upper surface point of agarose film 2 has ToRCH antigen protein microarray 3, and point has ToRCH antibody 4 (referring to Fig. 1) on the ToRCH antigen microarray 3.
Embodiment two
The ToRCH protein-chip of present embodiment adopts silicon chip as microslide 1, the upper surface of microslide 1 is attached with one deck glucosan---polyacrylamide film 2, the upper surface point of glucosan---polyacrylamide film 2 has ToRCH antigen protein microarray 3, and point has ToRCH antibody 4 on the ToRCH antigen microarray 3.
During inspection, be coated on clearly on the chip as long as will wait to have a blood test, in short time about two hours, just can finish all ToRCH diagnosis by a slice chip is disposable, very conveniently fast experimental results show that, its sensitivity and specificity are all very good, and its cost only is 30% of an import reagent box inspection charge.Therefore, after the release, will have very vast market prospect, have a tremendous social and economic benefits.
In addition to the implementation, the technical solution of the utility model also has other numerous embodiments.For example, microslide adopts Ge, GaAs, GaP, SiO2, Si3N4 sheet, or gel, glycan thing such as poly-tetrafluoro, poly-alum, polycarbonate; Macromolecule glycan film is an agarose---polyacrylamide base film or agarose---glucosan---polyacrylamide base film etc.; All employings are equal to the technical scheme of replacement or equivalent transformation formation, are the protection domain of the utility model requirement.

Claims (6)

1. a ToRCH protein-chip comprises microslide, it is characterized in that: described microslide is attached with macromolecule glycan film, and described macromolecule glycan film surface attachment has ToRCH antigen-antibody protein microarray.
2. ToRCH protein-chip according to claim 1 is characterized in that: described macromolecule glycan film upper surface point has ToRCH antigen protein microarray, and point has ToRCH antibody on the ToRCH antigen microarray.
3. ToRCH protein-chip according to claim 1 and 2 is characterized in that: described microslide is a glass, and the upper surface of described glass slide is attached with one deck agarose film.
4. ToRCH protein-chip according to claim 1 and 2 is characterized in that: described microslide is a silicon chip, and the upper surface of silicon chip microslide is attached with one deck glucosan---the polyacrylamide film.
5. according to claim 2 or 3 described ToRCH protein-chips, it is characterized in that: described microslide adopts Ge, GaAs, GaP, SiO2, Si3N4 sheet, or the gel glycan thing of poly-tetrafluoro, poly-alum, polycarbonate.
6. ToRCH protein-chip according to claim 1 is characterized in that: described macromolecule glycan film is an agarose---polyacrylamide film or agarose---glucosan---polyacrylamide film.
CN 01263165 2001-10-11 2001-10-11 ToRCH protein chip Expired - Fee Related CN2528018Y (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 01263165 CN2528018Y (en) 2001-10-11 2001-10-11 ToRCH protein chip

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 01263165 CN2528018Y (en) 2001-10-11 2001-10-11 ToRCH protein chip

Publications (1)

Publication Number Publication Date
CN2528018Y true CN2528018Y (en) 2002-12-25

Family

ID=33670798

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 01263165 Expired - Fee Related CN2528018Y (en) 2001-10-11 2001-10-11 ToRCH protein chip

Country Status (1)

Country Link
CN (1) CN2528018Y (en)

Similar Documents

Publication Publication Date Title
Pelloux et al. Determination of anti–Toxoplasma gondii immunoglobulin G avidity: adaptation to the Vidas system (bioMérieux)
Stray-Pedersen et al. The prevalence of toxoplasma antibodies among 11 736 pregnant women in Norway
ATE161960T1 (en) ISOLATION OF FETAL CELLS FROM MATERNAL BLOOD TO PERFORM PRENATAL DIAGNOSTICS
JP2002504222A (en) In situ immunodetection of antigen
CN1122614A (en) Method and device for detecting or measuring the amount of a cell-associated molecule
JPH08500181A (en) Screening method for Down's syndrome using dried blood samples
Tissot Dupont et al. Usefulness of Western blot in serological follow-up of newborns suspected of congenital toxoplasmosis
EP0670042A4 (en) Immunoassays for antibodies in urine to microorganisms associated with sexually transmitted diseases.
US20210349105A1 (en) Sars-cov-2 immunoassay and materials therefor
Ketema et al. Assessment of the performance of a rapid, lateral flow assay for the detection of antibodies to HIV
CN104155449A (en) Method and kit for detecting TORCH IgM antibodies and preparation method of kit
KR920007686B1 (en) Extraction composition test kit and their use to extract or determine herpes simplex viral antigen
CN2528018Y (en) ToRCH protein chip
CN1869700A (en) Sterility, infertility six-index integral investigating reaction plate and protein chip kit
CN111781360A (en) Free cell capture probes and related products and uses
CN1412557A (en) ToRCH protein chip and its preparation method
Taylor et al. Comparison of the ADVIA centaur® and Abbott AxSYM immunoassay systems for a routine diagnostic virology laboratory
JP2009515169A (en) Methods for determination of antibody IgG binding activity
JP2013527467A5 (en)
CN2486973Y (en) Multiple combined fast detection reagent box
CA1231047A (en) Diagnostic test for rheumatological diseases
Hamai et al. Quantitative Assessment of Human Leukocyte Antigen‐G Protein in Amniotic Fluid by a Double‐Determinant Enzyme‐Linked Immunosorbent Assay Using Anti‐Human Leukocyte Antigen‐G‐Specific Antibody ‘87G’
US20070160978A1 (en) Method for seriological diagnosis and determination of immunisation status, comprising various controls
WO2003023403A1 (en) A KIT FOR THE SIMULTANEOUS DIAGNOSIS OF FOUR KINDS OF DISEASES (ToRCH) RESULTING IN DEFORMITY FETUS AND A METHOD FOR PREPARATION OF IT
EP2200620A1 (en) Infectious disease testing of menstrual fluid, endometrial /menstrual cells, amniotic fluid, umbilical cord blood or other samples

Legal Events

Date Code Title Description
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee